09/11/2026
Most cancers have no routine screening test. That's the gap EPISEEK is built to address.
New clinical validation data from Precision Epigenomics show the multi-cancer blood test detecting cancer signals across 60+ types, with its strongest results in aggressive, hard-to-screen cancers like pancreatic, liver, stomach, and brain, often at the early stages that matter most.
It's one blood draw, and it works alongside your standard screening, not instead of it. Our latest article breaks down what the numbers show and what still needs confirming.
Learn more about EPISEEK Multi-Cancer Blood Test: New Clinical Validation Data and other important health info on our Calgary, Alberta Naturopathic Clinic blog